1Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT) : biological imaging and biological conforreality[J]. Int J Radiat Oncol Biol Phys, 2000, 47:551-560.
2Purdy JA. From new frontiers to new standards of practice: advances in radiotherapy planning and delivery[ J]. Front Radiat Ther Oncol, 2007, 40 : 18- 39.
3Purdy JA. Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques[J]. Health Phys, 2008, 95(5):666-676.
5Zanzonico P. PET-based biological imaging for radiation therapy treatment planning[J]. Crit Rev Eukaryot Gene Expr, 2006, 16 (1) :61-101.
6Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-metaanalytic comparison of PET and CT[ J]. Radiology, 1999, 213: 530-536.
7Eschmann SM, Friedel G, Paulsen F, et al. Impact of staging with ^18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivom[ J]. EurJ Nucl Med Mol, Imaging, 2007, 34:54-59.
8Moureau-Zabotto L, Touboul E, Lerouge D, et al. Impact of CT and ^18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma[ J]. Int J Radiat Oncol Biol Phys, 2005, 63(2):340-345.
9Vrieze O, Haustermans K, De Wever W, et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma [ J]. Radiother Oncol, 2004, 73 ( 3 ) : 269- 275.
10Hutchings M, Loft A, Hansen M, et al. Clinical impact of FDG- PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma[ J]. Eur J Haematol, 2007, 78 (3) :206-212.
